An Improved, Chemically Modified RNA Encoding BMP-2 Enhances Osteogenesis In Vitro and In Vivo.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30009674.
- Also identified by DOI 10.1089/ten.TEA.2018.0112.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The use of chemically modified RNA (cmRNA) with increased stability using translation initiator of short untranslated regions (TISU) offers the prospect of finally allowing us to unlock the potent osteogenic properties of BMP-2 in a clinically expedient manner. As noted, delivery of recombinant BMP-2 protein has had modest clinical efficacy, whereas gene delivery is effective but very difficult to translate into human clinical use. This study shows the great potential of cmRNA encoding BMP-2 with TISU in a long-bone critical-sized rat model.
Medical subject headings
- Bone Morphogenetic Protein 2
- Gene Transfer Techniques
- Mesenchymal Stem Cells
- Osteogenesis
- RNA, Messenger